Advair hfa and Ingrezza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Advair hfa (fluticasone propionate; salmeterol xinafoate) and Ingrezza (valbenazine tosylate). Common drug interactions include somnolence among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Advair hfa and Ingrezza. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Advair hfa?

Advair hfa has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 69,790 Advair hfa users. Check the latest studies of Advair hfa.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

47 people who take Advair hfa and Ingrezza together, and have interactions are studied.

Advair hfa and Ingrezza drug interactions.

What are the common drug interactions of Advair Hfa and Ingrezza, by gender? *:

female:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Fall
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Diarrhoea
  5. Drooling (drop saliva uncontrollably from the mouth)
  6. Facial paralysis (loss of function of face muscle)
  7. Fatigue (feeling of tiredness)
  8. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  9. Balance disorder
  10. Dizziness

male:

  1. Death
  2. Fatigue (feeling of tiredness)
  3. Irritability
  4. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Insomnia (sleeplessness)
  7. Drug ineffective
  8. Restlessness (not able to rest)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Thyroid disorder (thyroid diseases)

What are the common drug interactions of Advair Hfa and Ingrezza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Psoriasis (immune-mediated disease that affects the skin)

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Drooling (drop saliva uncontrollably from the mouth)
  3. Facial paralysis (loss of function of face muscle)
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Neck pain
  9. Adverse drug reaction
  10. Depressed level of consciousness

50-59:

  1. Dizziness
  2. Fall
  3. Dry mouth
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Headache (pain in head)
  6. Mastication disorder (disease of chewing food)
  7. Speech disorder
  8. Death
  9. Confusional state
  10. Dystonia (abnormal muscle tone)

60+:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Balance disorder
  3. Decreased appetite
  4. Haematochezia (passage of stools containing blood)
  5. Restless legs syndrome (a powerful urge to move your legs)
  6. Blood glucose increased
  7. Blood potassium increased
  8. Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
  9. Cardiac failure congestive
  10. Drug effect decreased

What are the existing conditions these people have? *

  1. Tardive Dyskinesia (a disorder that involves involuntary movements): 41 people, 87.23%
  2. Stress And Anxiety: 9 people, 19.15%
  3. Insomnia (sleeplessness): 8 people, 17.02%
  4. High Blood Cholesterol: 6 people, 12.77%
  5. Depression: 6 people, 12.77%
  6. High Blood Pressure: 5 people, 10.64%
  7. Pain: 4 people, 8.51%
  8. Hypersensitivity: 4 people, 8.51%
  9. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 6.38%
  10. Type 2 Diabetes: 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Advair hfa and Ingrezza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Advair hfa and Ingrezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Advair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ingrezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Advair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ingrezza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate; salmeterol xinafoate and valbenazine tosylate (the active ingredients of Advair hfa and Ingrezza, respectively), and Advair hfa and Ingrezza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: